Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Higher Volume and Proportion of Transradial Cases Linked with Lower Mortality

Michael O'Riordan

May 13, 2016

News Daily News

Observational Study Supports Longer-Term Monitoring for A-fib After Cryptogenic Stroke

Todd Neale

April 22, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

January 29, 2015

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation VEINS 2013

Switching Patients to the New Anticoagulants

Presenter: Suman Rathbun

September 21, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Jason Kahn

August 06, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Advertisement

Higher Volume and Proportion of Transradial Cases Linked with Lower Mortality

Observational Study Supports Longer-Term Monitoring for A-fib After Cryptogenic Stroke

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Switching Patients to the New Anticoagulants

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

ESC Offers Recommendations on Use of New Oral Anticoagulants

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content